Clinical Trials Sponsored by AudioPro Connect

Total 176 results

University Hospital, Montpellier
AudioPro Connect; Alliance Audition Montpellier; Audition Conseil Perpignan; Audition...

Completed

REFIT Hearing: Remote Fitting of Hearing Aids (REFITHEARING)

Hearing Loss

France
VWD Connect Foundation

Recruiting

The Severe Von Willebrand Disease (sVWD) Patient Registry

VWD - Von Willebrand's Disease

United States
Connect Biopharma Australia Pty Ltd

Completed

A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects

Autoimmune Diseases

Australia, United States
TAO Connect, Inc.

Unknown

TAO Outpatient Trial for Anxiety and Depression

Depression | Anxiety Disorders

United States
Connect Biopharma Australia Pty Ltd

Completed

Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults

Healthy Adult Subjects

Australia
Suzhou Connect Biopharmaceuticals, Ltd.

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD

Atopic Dermatitis

China
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects

Healthy Adult Subjects

China
Suzhou Connect Biopharmaceuticals, Ltd.

Terminated

A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

United States, China, Poland, Spain, Ukraine
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study On Human Mass Balance And Biotransformation

Healthy Adult Subjects

China
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Moderate to Severe Persistent Asthma

United States, China, Hungary, Korea, Republic of, Poland
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China

Moderate-to-severe Atopic Dermatitis

China
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

Moderate to Severe Ulcerative Colitis

United States, China, Pakistan, Ukraine
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

United States, Australia, China, New Zealand
Suzhou Connect Biopharmaceuticals, Ltd.

Withdrawn

CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis

Atopic Dermatitis

United States
Teesside University
Connect Health Ltd

Completed

An Evaluation of a Flippin' Pain Seminar Series

Chronic Pain

United Kingdom
Venus Concept

Completed

Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat Reduction

Adipose Tissue Atrophy

United States
Concert Pharmaceuticals

Enrolling by invitation

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
Concert Pharmaceuticals

Active, not recruiting

European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

Spain, Germany, Poland, France, Hungary
Venus Concept

Completed

Clinical Evaluation of the Safety and Efficacy of a 1060 nm Diode Laser (Flanks)

Fat Atrophy

United States
Venus Concept

Completed

Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring

Acne Scars - Mixed Atrophic and Hypertrophic

United States
Venus Concept

Completed

Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles

Wrinkle | Rhytides

United States
Venus Concept

Completed

Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring

Acne Scars

United States
Venus Concept

Completed

Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)

Fat Atrophy

United States
Venus Concept

Completed

Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity

Menopause | Vulvovaginal Atrophy | Menopause Surgical

Canada
Venus Concept

Completed

RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity

Menopause | Vulvovaginal Atrophy | Menopause Surgical

Canada
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543

Renal Impairment

United States
Concert Pharmaceuticals

Completed

Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects

Health Volunteers

United States
Concert Pharmaceuticals

Completed

Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects

Health Volunteers

United States
Concert Pharmaceuticals

Completed

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers

Healthy Volunteers

United States
Concert Pharmaceuticals

Completed

Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects

Healthy Volunteers

United States
Venus Concept

Completed

Clinical Evaluation of Fractional Radiofrequency for the Treatment of Acne Scarring

Acne Scars

United States
Concert Pharmaceuticals

Completed

Food Effect Study of CTP-543 in Healthy Volunteers

Healthy

United States
Concert Pharmaceuticals

Completed

Open-Label Crossover Study Comparing CTP-543 to Jakafi®

Healthy

United States
Concert Pharmaceuticals

Completed

Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656

Healthy

Australia
Concert Pharmaceuticals

Completed

Multiple Ascending Dose Study in Healthy Volunteers

Healthy

Australia
Concert Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499

Diabetic Nephropathy

United States
Venus Concept

Recruiting

Electrical Muscle Stimulation With 1064 nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.

Fat Reduction | Muscle Tone Increased

United States
Venus Concept

Recruiting

Robotic Mechanical Coring for the Treatment of Moderate to Severe Facial Wrinkles

Wrinkle

United States
Reconnect Labs

Completed

Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects (DHTP)

Healthy

Switzerland
Venus Concept

Completed

Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles

Wrinkle | Rhytides

United States
Venus Concept

Withdrawn

Subject Evaluation of a 1064nm Diode Laser/RF

Subcutaneous Fat Disorder

United States
Venus Concept

Completed

RF and PEMF Following Liposuction

Lipolysis

Spain
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
Concert Pharmaceuticals

Completed

Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543

Hepatic Impairment

United States
Concert Pharmaceuticals

Completed

Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

Health Volunteers

United States
Concert Pharmaceuticals

Completed

Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects

Healthy Volunteers

United States
Venus Concept

Completed

Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles

Acne Scars - Mixed Atrophic and Hypertrophic | Wrinkle

United States
Venus Concept

Terminated

Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference

Lipodystrophy

United States

3

Subscribe